National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
This grant funds the development of drug and device discovery groups aimed at treating mental disorders.
About this program
The National Cooperative Drug/Device Discovery/Development Groups (NCDDG) grant supports collaborative efforts in the discovery and development of new drugs and devices for the treatment of mental disorders. It is designed for research institutions, universities, and other organizations that are engaged in innovative research to address mental health challenges. The program encourages partnerships among various stakeholders to enhance the efficacy and efficiency of the development process. Eligible applicants can include academic institutions, nonprofit organizations, and private sector entities that have the capability to conduct clinical trials and contribute to the advancement of mental health treatments. The grant aims to foster a cooperative environment where different entities can share resources, knowledge, and expertise to accelerate the development of effective therapeutic solutions. This initiative is particularly focused on addressing unmet needs in mental health care through innovative approaches and collaborative research efforts.
Eligibility
Research institutions, universities, nonprofit organizations, and private sector entities engaged in mental health research.